Edition:
United Kingdom

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

166.08USD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
$166.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
690,394
52-wk High
$197.00
52-wk Low
$114.27

Greenberg, Michael 

Dr. Michael E. Greenberg, Ph.D. is Director of the Company. Dr. Greenberg has been Harvard University’s Nathan Marsh Pusey Professor of Neurobiology since 2008. He has been a Co-Leader of Harvard Medical School’s Allen Discovery Center for Human Brain Evolution since 2017 and Chair of the Department of Neurobiology since 2008. He was also Founding Director of the F.M. Kirby Neurobiology Center, Children’s Hospital Boston, where he continues to serve as director. Prior to that he was a Professor in the Department of Microbiology & Molecular Genetics at Harvard Medical School. Dr. Greenberg earned his Doctor of Philosophy from Rockefeller University and a Bachelor of Arts degree from Wesleyan University. He completed his post-doctoral fellowship at New York University Medical Center. He currently serves on the Scientific Advisory Board of Decibel Therapeutics.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --